Can planned CD34+ stem cell boost prevent poor graft function after peripheral blood haploidentical hematopoietic transplantation?

Ramzi AbboudDivision of Oncology, Washington University School of Medicine, St. Louis, MO, USACorrespondence[email protected]

https://orcid.org/0000-0001-7786-4155 View further author information

Michael SladeDivision of Oncology, Washington University School of Medicine, St. Louis, MO, USAView further author information

Camille AbboudDivision of Oncology, Washington University School of Medicine, St. Louis, MO, USAView further author information

John F. DiPersioDivision of Oncology, Washington University School of Medicine, St. Louis, MO, USAView further author information

Click to increase image sizeClick to decrease image size

Disclosure statement

RA, MS, CNA, and JFD have nothing to disclose regarding this manuscript.

Author contributions

Contribution: The first draft of the manuscript was written by RA. MS, CNA, and JFD contributed to subsequent drafts and revisions. RA performed statistical analysis.

Additional information

Funding

RA is supported by the American Society of Hematology Clinical Research Training Institute and the American Society of Hematology Training Award for Fellows.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Can planned CD34+ stem cell boost prevent poor graft function after peripheral blood haploidentical hematopoietic transplantation?

Information for

Open access

Opportunities

Help and information

Can planned CD34+ stem cell boost prevent poor graft function after peripheral blood haploidentical hematopoietic transplantation?

Disclosure statement

Author contributions

Additional information

Funding

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date

Your download is now in progress and you may close this window

Login or register to access this feature